Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded
- Contract number
- SPE2DB26FRHKP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,163
Award facts
- Contract value 100% obligated
- $22,163.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) valued at $22,163.48. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of October 31, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor headquartered in Pennsylvania, serving military and veteran healthcare systems through competitive contract awards. The company's extensive federal contract portfolio with DLA demonstrates its capability to supply a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. This delivery order for Ozempic, a diabetes management medication, reflects the company's role as a key supplier within the DLA's pharmaceutical prime vendor global program supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FRHKP?
SPE2DB26FRHKP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FRHKP worth?
The government has obligated $22,163 on SPE2DB26FRHKP.
Is contract SPE2DB26FRHKP an order under another contract?
Yes. SPE2DB26FRHKP is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB26FRHKP competed?
The extent of competition for SPE2DB26FRHKP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award